熱景生物(688068.SH)擬以不超1000萬元超募資金購買土地 擴大募投項目實施場地
格隆匯5月12日丨熱景生物(688068.SH)公佈,公司擬使用不超過1000萬元超募資金在原募集資金投資項目北側購買20畝土地使用權,用於擴大募集資金投資項目“年產1,200萬人份體外診斷試劑、850台配套儀器生產基地及研發中心項目”的實施場地。
原募集資金投資項目“年產1,200萬人份體外診斷試劑、850台配套儀器生產基地及研發中心項目”實施主體為廊坊熱景,項目建設地址為廊坊經濟技術開發區廊坊聯合重工製造有限公司南側、官東路西側。
擬投入募集資金2.88億元,形成新增年產1200萬人份體外診斷試劑、850台配套儀器的生產能力及研發中心。主要建設內容包括購置土地、廠房建設、生產設備、鋪底流動資金等。原募投項目完全達產後,預計實現年營業收入2.14億元,實現淨利潤4497.05萬元,項目投資回收期為8.05年。
募投項目的實施地點為廊坊經濟技術開發區廊坊聯合重工製造有限公司南側、官東路西側30畝地塊。該地塊為長257米、寬77米的長條形地塊,雖公司已於2019年1月取得廊開經內資備[2019]19號的備案許可,並於2019年6月獲得一期工程(倉庫單體)的施工許可,但該長條形地塊不利於公司生產建設佈局。
擬購買地塊位於公司募投項目北側,為工業用地,共計20畝;地塊購買後將和原有募投項目用地合併為50畝的工業用地,地塊變更為長257米、寬129米的長方形地塊,相比原來長度不變、寬度增加52米。新購用於擴大募集資金投資項目實施場地,可以利用在建募投項目用地的北側共有道路,滿足廠內運輸和消防要求;在合併地塊基礎上對原有建設項目佈局進行調整,擴大募集資金投資項目實施場地,更有利於生產的合理佈局,達到集約用地的目的;並可為進一步增加生產車間和產能擴張預留空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.